Zhejiang Jianfeng Group Co., Ltd. Third Quarter Report 2018 Text
Release time:
2020-07-07
公司代码:600668 公司简称:尖峰集团
浙江尖峰集团股份有限公司
2018年第三季度报告正文
一、 重要提示
1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。
1.2 公司全体董事出席董事会审议季度报告。
1.3 公司负责人蒋晓萌、主管会计工作负责人兰小龙及会计机构负责人(会计主管人员)吴德富保证季度报告中财务报表的真实、准确、完整。
1.4 本公司第三季度报告未经审计。
二、 公司主要财务数据和股东变化
2.1 主要财务数据
单位:元 币种:人民币
|
|
本报告期末 |
上年度末 |
本报告期末比上年度末增减(%) |
|
总资产 |
4,787,531,214.62 |
4,175,730,846.73 |
14.65 |
|
归属于上市公司股东的净资产 |
3,091,664,703.46 |
2,627,318,888.65 |
17.67
|
|
|
年初至报告期末 (1-9月) |
上年初至上年报告期末 (1-9月) |
比上年同期增减(%) |
|
经营活动产生的现金流量净额 |
375,343,924.71 |
194,680,761.60 |
92.80 |
|
|
年初至报告期末 (1-9月) |
上年初至上年报告期末 (1-9月) |
比上年同期增减 (%) |
|
营业收入 |
2,308,365,252.61 |
1,966,202,048.98 |
17.40 |
|
归属于上市公司股东的净利润 |
488,183,289.95 |
291,408,643.10 |
67.53 |
|
归属于上市公司股东的扣除非经常性损益的净利润 |
473,663,318.81 |
277,934,952.23 |
70.42 |
|
加权平均净资产收益率(%) |
17.05 |
11.74 |
增加5.31个百分点 |
|
基本每股收益(元/股) |
1.4188 |
0.8469 |
67.53 |
|
稀释每股收益(元/股) |
1.4188 |
0.8469 |
67.53 |
非经常性损益项目和金额
单位:元 币种:人民币
|
项目 |
本期金额 (7-9月) |
年初至报告期末金额(1-9月) |
说明 |
|
非流动资产处置损益 |
17,071.47 |
25,797.10 |
|
|
越权审批,或无正式批准文件,或偶发性的税收返还、减免 |
1,344,590.41 |
2,037,104.39 |
|
|
计入当期损益的政府补助,但与公司正常经营业务密切相关,符合国家政策规定、按照一定标准定额或定量持续享受的政府补助除外 |
6,010,443.10 |
15,471,116.32 |
|
|
委托他人投资或管理资产的损益 |
169,552.87 |
1,535,544.14 |
|
|
除上述各项之外的其他营业外收入和支出 |
-24,177.80 |
-680,195.47 |
|
|
少数股东权益影响额(税后) |
-346,385.71 |
-472,835.16 |
|
|
所得税影响额 |
-1,511,067.33 |
-3,396,560.18 |
|
|
合计 |
5,660,027.01 |
14,519,971.14 |
|
2.2 截止报告期末的股东总数、前十名股东、前十名流通股东(或无限售条件股东)持股情况表
单位:股
|
股东总数(户) |
29,258 |
||||||
|
前十名股东持股情况 |
|||||||
|
股东名称 (全称) |
期末持股数量 |
比例(%) |
持有有限售条件股份数量 |
质押或冻结情况 |
股东性质 |
||
|
股份状态 |
数量 |
||||||
|
金华市通济国有资产投资有限公司 |
55,564,103 |
16.15 |
0 |
无 |
0 |
国有法人 |
|
|
国通信托有限责任公司-国通信托·惠钰1号单一资金信托 |
9,234,900 |
2.68 |
0 |
无 |
0 |
未知 |
|
|
国民信托有限公司-国民信托·华富3号证券投资单一资金信托 |
6,922,000 |
2.01 |
0 |
无 |
0 |
未知 |
|
|
香港中央结算有限公司 |
4,510,078 |
1.31 |
0 |
无 |
0 |
未知 |
|
|
浙江康恩贝制药股份有限公司 |
3,742,992 |
1.09 |
0 |
无 |
0 |
境内非国有法人 |
|
|
何文康 |
3,439,100 |
1.00 |
0 |
无 |
0 |
境内自然人 |
|
|
王晓红 |
3,121,943 |
0.91 |
0 |
无 |
0 |
境内自然人 |
|
|
骆惠娟 |
2,976,200 |
0.86 |
0 |
无 |
0 |
境内自然人 |
|
|
钟以隆 |
2,650,000 |
0.77 |
0 |
无 |
0 |
境内自然人 |
|
|
徐新华 |
2,544,661 |
0.74 |
0 |
无 |
0 |
境内自然人 |
|
|
前十名无限售条件股东持股情况 |
|||||||
|
股东名称 |
持有无限售条件流通股的数量 |
股份种类及数量 |
|||||
|
种类 |
数量 |
||||||
|
金华市通济国有资产投资有限公司 |
55,564,103 |
人民币普通股 |
55,564,103 |
||||
|
国通信托有限责任公司-国通信托·惠钰1号单一资金信托 |
9,234,900 |
人民币普通股 |
9,234,900 |
||||
|
国民信托有限公司-国民信托·华富3号证券投资单一资金信托 |
6,922,000 |
人民币普通股 |
6,922,000 |
||||
|
香港中央结算有限公司 |
4,510,078 |
人民币普通股 |
4,510,078 |
||||
|
浙江康恩贝制药股份有限公司 |
3,742,992 |
人民币普通股 |
3,742,992 |
||||
|
何文康 |
3,439,100 |
人民币普通股 |
3,439,100 |
||||
|
王晓红 |
3,121,943 |
人民币普通股 |
3,121,943 |
||||
|
骆惠娟 |
2,976,200 |
人民币普通股 |
2,976,200 |
||||
|
钟以隆 |
2,650,000 |
人民币普通股 |
2,650,000 |
||||
|
徐新华 |
2,544,661 |
人民币普通股 |
2,544,661 |
||||
|
上述股东关联关系或一致行动的说明 |
本公司第一大股东通济国投与其他上述第2名至第10名无限售条件股东之间不存在关联关系。公司未知其他9名股东之间是否存在关联关系,也未知是否属于《上市公司收购管理办法》规定的一致行动人。 |
||||||
|
表决权恢复的优先股股东及持股数量的说明 |
不适用 |
||||||
2.3 截止报告期末的优先股股东总数、前十名优先股股东、前十名优先股无限售条件股东持股情况表
三、 重要事项
3.1 公司主要会计报表项目、财务指标重大变动的情况及原因
|
资产负债表项目 |
期末数(万元) |
期初数(万元) |
变动幅度 |
变动原因 |
|
预付帐款 |
10,245.02 |
4,610.82 |
122.20% |
主要系本报告期子公司预付货款增加所致。 |
|
其他应收款 |
2,095.55 |
1,308.75 |
60.12% |
主要系报告期公司的投资单位已宣告但尚未发放的现金股利增加所致。 |
|
其他流动资产 |
14,482.18 |
1,328.92 |
989.77% |
主要系报告期公司购买的短期银行结构性存款理财产品所致。 |
|
投资性房地产 |
7,964.52 |
2,145.61 |
271.20% |
主要系报告期子公司尖峰国贸在建电商物流园项目部分结转增加所致。 |
|
在建工程 |
2,542.40 |
4,557.67 |
-44.22% |
主要系报告期子公司在建工程项目部分结转相应资产所致。 |
|
商誉 |
7,549.90 |
1,629.86 |
363.22% |
主要系报告期公司新增合并企业上海北卡所致。 |
|
长期待摊费用 |
244.21 |
175.03 |
39.52% |
主要系报告期公司新增合并企业上海北卡所致。 |
|
短期借款 |
14,900.00 |
8,900.00 |
67.42% |
主要系报告期公司及子公司增加银行借款所致。 |
|
应付职工薪酬 |
1,267.86 |
3,627.55 |
-65.05% |
主要系报告期公司及子公司发放上年末计提的年终奖所致。 |
|
其他应付款 |
28,672.64 |
17,432.86 |
64.47% |
主要系报告期子公司计提的市场推广费和其他支出增加及子公司股东会决议宣告但尚未发放的2017年度现金股利增加所致。 |
|
一年内到期的非流动负债 |
0.00 |
27,631.69 |
-100.00% |
主要系报告期公司按期兑付到期的公司债券所致。 |
|
长期借款 |
13,200.00 |
0.00 |
100.00% |
主要系报告期公司新增的长期银行借款及新增合并企业众望制药所致。 |
|
少数股东权益 |
27,469.76 |
19,695.14 |
39.47% |
主要系报告期公司新增合并企业上海北卡所致。 |
|
利润表项目 |
本期数(万元) |
上年同期数(万元) |
变动幅度 |
变动原因 |
|
税金及附加 |
2,156.55 |
1,414.54 |
52.46% |
主要系报告期子公司营业收入增加相应的税金及附加增加所致。 |
|
销售费用 |
34,510.47 |
19,767.16 |
74.58% |
主要系报告期子公司尖峰药业销售收入的增长和销售模式的调整,公司销售费用中相应增加了市场推广费和其他支出。 |
|
投资收益 |
17,306.51 |
10,365.66 |
66.96% |
主要系报告期公司联营投资单位南方尖峰水泥有限公司利润大幅增长,公司权益法核算计入投资收益相应增加所致。 |
|
所得税费用 |
11,927.05 |
7,392.18 |
61.35% |
主要系本报告期子公司实现的利润总额增加相应的所得税费用增加所致。 |
|
现金流量表项目 |
|
|
|
|
|
经营活动产生的现金流量净额 |
37,534.39 |
19,468.08 |
92.80% |
主要系报告期公司销售收入增长及营业利润大幅增加所致。 |
|
投资活动产生的现金流量净额 |
-24,857.50 |
-21,162.20 |
|
|
|
筹资活动产生的现金流量净额 |
-19,354.57 |
-5,320.98 |
|
主要系报告期公司到期兑付了公司债券本金及利息所致。 |
3.2 重要事项进展情况及其影响和解决方案的分析说明
1.2017年8月3日,本公司九届14次董事会通过了《关于山亚南方股权重组的关联交易的议案》。
本公司控股子公司尖峰水泥持有南方尖峰35%股权,金华南方水泥有限公司(以下简称“金华南方”)持有南方尖峰65%股权;南方尖峰持有杭州山亚南方水泥有限公司(以下简称“山亚南方”)的100%股权。为了压减企业层级、提高运营效率,拟对山亚南方进行股权重组,南方尖峰将所持有的山亚南方100%股权上移,分别转让给尖峰水泥与金华南方两个股东,尖峰水泥与金华南方按所占南方尖峰的股权比例受让山亚南方股权,其中:尖峰水泥拟出资62,099,765元受让山亚南方的35%股权;金华南方拟出资115,328,135元受让山亚南方的65%股权。股权重组完成后,山亚南方的股权层级将上移,重组前后本公司所持该股权的整体权益没有变化。详见2017年8月3日本公司在上海证券交易所网站披露的临2017-019《关于山亚南方股权重组的关联交易公告》。截止报告期末,因支付股权转让款的前提条件尚未达到,该股权重组事项尚未实施。该事项不会影响公司所持的该股权的整体权益。
2.2018年8月3日,公司十届5次董事会通过了《关于子公司尖峰药业对上海北卡增资的议案》本公司控股子公司尖峰药业出资人民币5000万元,自然人吴江出资人民币1000万元,对上海北卡进行增资,其他股东放弃参与本次增资。上述事项详见2018年8月4日本公司披露于上海证券交易所网站(http//:www.sse.com.cn/)的临2018-022《十届5次董事会决议公告》和临2018-025《关于子公司尖峰药业对上海北卡增资的公告》。截止报告期末,本次增资事宜已经完成,上海北卡已经完成了工商变更登记手续。上海北卡注册资本由原来的1755.55万元增加至2275.93万元,其中尖峰药业占61.48%。
3. 2018年8月3日,公司十届5次董事会通过了《关于子公司上海北卡收购安徽众望的议案》。本公司控股子公司上海北卡医药技术有限公司出资2062万元,收购安徽众望制药有限公司的全部100%股权,收购完成后安徽众望将成为上海北卡的全资子公司。上述事项详见2018年8月4日本公司披露于上海证券交易所网站(http//:www.sse.com.cn/)的临2018-022《十届5次董事会决议公告》和临2018-023《关于子公司上海北卡收购安徽众望的公告》。截止报告期末,该股权收购事宜已经完成,安徽众望已经完成工商变更登记手续,成为上海北卡的全资子公司。
4. 2018年8月3日,公司十届5次董事会通过了《关于尖峰药业金西生产基地年产20亿片固体制剂项目的议案》,同意尖峰药业投资建设金西生产基地年产20亿片固体制剂项目。上述事项详见2018年8月4日本公司披露于上海证券交易所网站(http//:www.sse.com.cn/)的临2018-022《十届5次董事会决议公告》和临2018-024《关于尖峰药业金西生产基地年产20亿片固体制剂项目的公告》。截止报告期末,金西生产基地年产20亿片固体制剂项目的土地指标已经落实,主体工艺设备选型基本完成,工艺设计正在进行中。
5.2017年2月29日,公司九届十次董事会审议通过的《关于子公司对外投资的议案》,本公司控股子公司浙江尖峰药业有限公司拟以增资和股权转让的方式,分期对北京慧宝源生物技术股份有限公司进行投资,其中:第一期出资8,000万元,以每股4元的价格对慧宝源生物增资2,000万股;第二期出资8,600万元,以每股4.30元的价格对慧宝源生物增资2,000万股,另出资3,010万元以每股4.30元的价格受让桂林商源出让的慧宝源生物股权700万股;第三、第四期各对慧宝源生物增资1,400万股,增资价格以届时各方共同认可并聘请的具有证券从业资格的资产评估机构进行评估,以评估结果为基础协商确定。截止报告期末,浙江尖峰药业有限公司已完成了第一期出资,占北京慧宝源生物技术股份有限公司20%的股权。
3.3 报告期内超期未履行完毕的承诺事项
3.4 预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生重大变动的警示及原因说明
|
公司名称 |
浙江尖峰集团股份有限公司 |
|
法定代表人 |
蒋晓萌 |
|
日期 |
2018年10月30日 |
- 发布时间: 2018-10-31
More information
Spike Cable Enters South American Market
Recently, a batch of 2100-pair communication cables produced by Peak Cable Company for Venezuelan customers have been completed and will be shipped in cabinets. This is the company's first export business in the South American market. In recent years, under the general trend of "light in and copper out" in the domestic market, Jianfeng Cable Company has taken the initiative to open up foreign markets that still use copper-core communication cables. While making use of its own production advantages to actively cooperate with domestic industry and trade enterprises to carry out foreign trade processing of communication cables, it has made great efforts to expand its own export business through foreign trade platforms and participation in exhibitions. Since the beginning of this year, the cable company has overcome the adverse effects of the new coronary pneumonia epidemic, actively looking for foreign customers for business negotiations, and won orders from Vietnamese customers shortly after the resumption of work. It is understood that in all the export business of cable companies this year, self-operated export business has accounted for about half, and the export direction is mainly Southeast Asia. The successful completion of the Venezuelan customer orders for the future further development of Colombia, Argentina, Peru, Chile and other South American countries to lay a good foundation. (Hu Longgang, Huang Yuan)
2020
11-12
Daye peak "war epidemic" work was commended by Hubei Province, Huangshi City
Recently, Daye Peak Cement Company won the commendation of Hubei Provincial Federation of Industry and Commerce, Hubei General Chamber of Commerce, Huangshi City Federation of Industry and Commerce, Huangshi City Chamber of Commerce, Huangshi City People's Government Poverty Alleviation and Development Office and other relevant units for its outstanding achievements in the prevention and control of the new coronary pneumonia epidemic. Since the beginning of this year, in the face of the new coronary pneumonia epidemic, Daye Peak has fully implemented the important instructions of the municipal government on the prevention and control of the new coronary pneumonia epidemic and the decision-making and deployment of poverty alleviation, obeying the overall situation, not only donating money to the Daye Municipal People's Government for the first time to help prevent and control the epidemic, but also actively do a good job in the prevention and control of the internal epidemic, and to resume production, and earnestly implement the municipal party committee and municipal government on the response to the impact of the new coronary pneumonia epidemic to carry out "two help two help" and "three get one stable" work requirements, paired to help the surrounding rural part of the population has not been lifted out of poverty, to help poor areas to solve the problem of agricultural and sideline products sales, for the city's decisive fight against poverty to contribute. (Yang Huiping, Zhang Qingyu)
2020
11-12
Liu Haiping, Vice Mayor of Pu'er, went to Yunnan Jianfeng for investigation
On the morning of November 3, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of the municipal government, and responsible persons of relevant departments went to Yunnan Jianfeng cement Company for investigation and discussion with Zhou Jiping, general manager of Yunnan Jianfeng, and Fang Xuhua, deputy general manager, on such topics as improving the business environment of Pu'er City and the difficulties encountered in the production and operation of enterprises. During the exchange, Zhou Jiping reported on the production and operation of the company this year, as well as the impact of the new coronary pneumonia epidemic on the market and the difficulties encountered in the production and operation process. Liu Haiping fully affirmed the efforts and achievements made since the resumption of work and production in Yunnan Peak, and said that a good business environment is very important for economic development and enhancing the vitality of enterprises. The functional departments of Pu'er government at all levels will continue to optimize various tasks, improve work efficiency, and provide services and guarantees for the development of enterprises. Liu Haiping hopes that Yunnan Jianfeng, as a key enterprise and "benchmark enterprise" in Pu'er City, will play a pioneering and exemplary role and jointly promote the construction of the business environment in Pu'er City. (qi jianmei)
2020
11-12
On the afternoon of November 10, the Party committee of the group company held an enlarged meeting to learn the spirit of the Fifth Plenary Session of the 19th CPC Central Committee and make arrangements for the next step of study, publicity and implementation. At the meeting, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, together with all members of the Party committee, members of the management team of the group company, heads of functional departments and some party members, studied the communique of the Fifth Plenary Session of the 19th CPC Central Committee and interpreted the spiritual points of the plenary session. Jiang Xiaomeng pointed out that the Fifth Plenary Session of the 19th Central Committee of the Communist Party of China, held in Beijing from October 26 to 29, is a very important meeting held at an important historical moment when the victory of building a moderately prosperous society in an all-round way is in sight and the new journey of building a modern socialist country in an all-round way is about to begin. It fully embodies the foresight of the Party Central Committee with Comrade Xi Jinping as the core in planning the future and the historical responsibility of carrying forward the past, and profoundly points out the guidelines, objectives, tasks, and strategic measures for China's development in the coming period. It is of great and far-reaching significance to mobilize and encourage the whole Party and the people of the whole country to continue to seize the important strategic opportunity period and promote the comprehensive construction of a socialist modern country. In response to the goals and some hot issues raised in the plenary communiqué, such as how to achieve the 2035 long-term goal, the key goals of economic and social development during the "14th Five-Year Plan" period, why the emphasis is on adhering to the party's overall leadership and strengthening the centralized and unified leadership of the party Central Committee. The main risks and challenges facing economic development in the next five years, how to achieve scientific and technological self-reliance, promote innovation, how to understand the construction, jiang Xiaomeng quoted the answers given by the leaders of relevant central ministries and commissions at the press conference of the plenary session. Jiang Xiaomeng emphasized that China's current development environment is facing profound and complex changes, and there are new developments and changes in opportunities and challenges. The guiding ideology and principles of economic and social development during the "14th Five-Year Plan" period proposed by the plenary session, and the economy during the "14th Five-Year Plan" period The main goals of social development will have a direct impact on the future development of our enterprises. Party organizations at all levels and all employees at the peak must study and study carefully, find the entry point and direction of work, make every effort to complete the annual work goals, and make preparations for the next year. The person in charge of the party organization of the company's overseas enterprises participated in the study through the video conference system. (this newspaper reporter)
2020
11-12
Zhou Zhou, executive vice governor of Qiandongnan Prefecture, sent a message to Huang Ping Jianfeng: fully promote the normalization of production and marketing to make new contributions to Huang Ping's overall well-off society. On October 27, Zhou Zhou, executive vice governor of Qiandongnan Prefecture, Guizhou Province, Yang Zhi, head of Huangping County, and relevant officials of the state and county governments went to Guizhou Huangping Jianfeng Cement Company to investigate and understand the project construction and production situation, and hope that the enterprises will develop as soon and promote regional economic development. Hu Hongwei, general manager of Huang Ping Jianfeng, and other members of the management team made a report on the overall work since the construction of the project started, and accompanied Zhou Zhou Zhou and his party to visit the production line site. In the central control room, Hu Hongwei to Zhou Zhou
2020
11-03
Zhang Xinyu, Vice Mayor of Jinhua City, hopes that Jianfeng Pharmaceutical will aim at cutting-edge science and technology to speed up the development of enterprises. On the afternoon of October 16, Zhang Xinyu, Vice Mayor of Jinhua City, and his party went to the construction site of Jianfeng Pharmaceutical's internationalization project of producing 2 billion pieces of solid preparations annually to conduct research. Accompanied by Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, and Shen Quan, deputy general manager of the pharmaceutical company, Zhang Xinyu and his entourage visited the preparation workshop under construction and affirmed the civilized construction and safety management of the site. Huang Jinlong introduced the basic situation of the project to Zhang Xinyu and his party. Knowing that Jianfeng Pharmaceutical has introduced world-class production equipment and advanced technology to build a high-end preparation manufacturing platform in order to achieve industrial upgrading, Zhang Xinyu expressed his appreciation and encouraged Jianfeng Pharmaceutical to gain a foothold in China, aim at the world's cutting-edge technology, and accelerate the pace of enterprise development. Continuously enhance the overall competitiveness of the enterprise. (Wang xuesheng/Wen Zhou hengbin/photo)
2020
11-03